Genomic Health Q4 Revenues Rise 22 Percent; International Ef

Genomic Health reported recently that its fourth quarter revenues rose 22 percent year over year, beating the consensus Wall Street estimate of $101.5 million. For the three months ended Dec. 31, 2018, the companys total revenues were $104.6......More>>

Roche will acquire Spark gene therapy for nearly $5 billion

Recently, the Wall Street Journal reported that Swiss biopharmaceutical company Roche is acquiring US technology company Spark Theraputics, which may be announced on Monday. The acquisition will value Sparks nearly $5 billion, while the Nasd......More>>

$21.4 billion! Danaher buys GE Life Sciences' biopharma busi

Danaher Corporation announced that it has entered into a definitive agreement with General Electric to acquire GE Life Sciences GE Biopharma business with a cash purchase price of approximately $21.4 billion. Given the expected tax benefits......More>>

Icon Acquires MolecularMD

Icon, an international drug-development and commercialization services firm, has acquired MolecularMD for an undisclosed amount, the companies said recently. MolecularMD, based in Portland, Oregon, is a molecular diagnostic laboratory that s......More>>

Exact Sciences' Q4 Revenues Up 64 Percent

Exact Sciences reported after the close of the market recently that its fourth quarter revenues rose 64 percent year over year, thanks to a 66 percent increase in the number of completed Cologuard colorectal cancer tests during the quarter.......More>>

GenMark Diagnostics Q4 Revenues Rise 21 Percent

GenMark Diagnostics reported after the close of the market recently that its fourth quarter revenues rose 21 percent year over year,in line withpreliminary Q4 revenuesreported in January. For the three months ended Dec. 31, 2018, the company......More>>